Targeted delivery of oral vaccine antigens to aminopeptidase N protects pigs against pathogenic E. coli challenge infection

被引:2
|
作者
van der Weken, Hans [1 ]
Jahantigh, Hamid Reza [2 ,3 ]
Cox, Eric [1 ]
Devriendt, Bert [1 ]
机构
[1] Univ Ghent, Fac Vet Med, Dept Translat Physiol Infectiol & Publ Hlth, Lab Immunol, Merelbeke, Belgium
[2] Emory Univ, Fac Med, Dept Pathol, Atlanta, GA USA
[3] Univ Bari, Interdisciplinary Dept Med, Sect Occupat Med, Bari, Italy
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
oral vaccination; challenge infection; E; coli; aminopeptidase N; epithelial targeting; mucosal immunity; recombinant antibody; subunit vaccine; ESCHERICHIA-COLI; EDEMA DISEASE; M CELLS; RECEPTOR; IGA; EFFICACY;
D O I
10.3389/fimmu.2023.1192715
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oral subunit vaccines are an interesting alternative strategy to traditional live-attenuated or inactivated vaccines for conferring protection against gut pathogens. Despite being safer and more cost-effective, the development of oral subunit vaccines remains challenging due to barriers imposed by the gastrointestinal tract, such as digestive enzymes, a tolerogenic immune environment and the inability of larger proteins to cross the epithelial barrier. Recent advances have focused on overcoming these barriers by using potent mucosal adjuvants or pH-responsive delivery vehicles to protect antigens from degradation and promote their release in the intestinal lumen. A promising approach to allow vaccine antigens to pass the epithelial barrier is by their targeting towards aminopeptidase N (APN; CD13), an abundant membrane protein present on small intestinal enterocytes. APN is a peptidase involved in digestion, but also a receptor for several enteric pathogens. In addition, upon antibody-mediated crosslinking, APN facilitated the transport of antibody-antigen fusion constructs across the gut epithelium. This epithelial transport resulted in antigen-specific immune responses. Here, we present evidence that oral administration of APN-specific antibody-antigen fusion constructs comprising the porcine IgA Fc-domain and the FedF tipadhesin of F18-fimbriated E. coli elicited both mucosal and systemic immune responses and provided at least partial protection to piglets against a subsequent challenge infection with an F18-fimbriated STEC strain. Altogether, these findings will contribute to the further development of new oral subunit vaccines and provide a first proof-of-concept for the protective efficacy of APN-targeted vaccine antigens.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
    Gabitzsch, Elizabeth
    Safrit, Jeffrey T.
    Verma, Mohit
    Rice, Adrian
    Sieling, Peter
    Zakin, Lise
    Shin, Annie
    Morimoto, Brett
    Adisetiyo, Helty
    Wong, Raymond
    Bezawada, Ashish
    Dinkins, Kyle
    Balint, Joseph
    Peykov, Victor
    Garban, Hermes
    Liu, Philip
    Bacon, Andrew
    Bone, Pete
    Drew, Jeff
    Sanford, Daniel C.
    Spilman, Patricia
    Sender, Lennie
    Rabizadeh, Shahrooz
    Niazi, Kayvan
    Soon-Shiong, Patrick
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection
    Han, Yue
    Liu, Qing
    Yi, Jie
    Liang, Kang
    Wei, Yunan
    Kong, Qingke
    PATHOGENS AND DISEASE, 2017, 75 (08):
  • [33] Bacterial ghosts as an oral vaccine:: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge
    Mayr, UB
    Haller, CH
    Haidinger, W
    Atrasheuskaya, A
    Bukin, E
    Lubitz, W
    Ignatyev, G
    INFECTION AND IMMUNITY, 2005, 73 (08) : 4810 - 4817
  • [34] Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection
    Je Hyoung Kim
    Irshad Ahmed Hajam
    John Hwa Lee
    Veterinary Research, 49
  • [35] Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection
    Kim, Je Hyoung
    Hajam, Irshad Ahmed
    Lee, John Hwa
    VETERINARY RESEARCH, 2018, 49
  • [36] Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09
    Said, Abdelrahman
    Lange, Elke
    Beer, Martin
    Damiani, Armando
    Osterrieder, Nikolaus
    VIRUS RESEARCH, 2013, 173 (02) : 371 - 376
  • [37] Oral vaccination of guinea pigs with a mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis
    Clark, Simon
    Cross, Martin L.
    Nadian, Allan
    Vipond, Julia
    Court, Pinar
    Williams, Ann
    Hewinson, R. Glyn
    Aldwell, Frank E.
    Chambers, Mark A.
    INFECTION AND IMMUNITY, 2008, 76 (08) : 3771 - 3776
  • [38] Towards a vaccine for attaching/effacing (A/E) E.coli:: A ler (LEE encoded regulator) mutant of an 0103:H- rabbit enteropathogenic E.coli (REPEC) is attenuated, immunogenic and protects against challenge with the parent strain.
    Feng, SH
    Zhu, CR
    Kaper, JB
    Boedeker, EC
    GASTROENTEROLOGY, 2001, 120 (05) : A126 - A126
  • [39] Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic E. coli Strains Expressing Different Colonization Factorsina Mouse Pulmonary Challenge Model
    Hays, Michael P.
    Kumar, Amit
    Martinez-Becerra, Francisco J.
    Hardwidge, Philip R.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2016, 6
  • [40] Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus
    Van Reeth, Kristien
    Braeckmans, Debby
    Cox, Eric
    Van Borm, Steven
    van den Berg, Thierry
    Goddeeris, Bruno
    De Vleeschauwer, Annebel
    VACCINE, 2009, 27 (45) : 6330 - 6339